Deal Tracker · Countries

Algeria pharma deals

12 pharma deals involving Algeria — companies based there or deals covering the market — tracked by EPT: localization, partnerships & M&A. Most active: Groupe Saidal, Alfasigma, Algerian laboratories & Biocare. Latest: Algerian laboratories → Tunisian, Mauritanian and Jordanian laboratories (Partnership / Collaboration, 24 Oct 2026).

12
deals tracked
11
announced in 2026
$410m
disclosed value (2 deals)
50%
localization, the top deal type
  • EPT has tracked 12 Algeria pharma deals (2025–2026), 11 of them announced in 2026.
  • The most common structures are localization (50%), partnerships (33%) & m&a (17%).
  • Values were disclosed for 2 of 12 deals, totalling $410m; the largest is DKSH → NewBridge Pharmaceuticals ($390m, 19 Oct 2026).
  • The most active companies: Groupe Saidal (4).

Most active companies

Groupe Saidal (4)

Countries involved

Kuwait (3) · Oman (3) · Tunisia (3) · Egypt (2) · Jordan (2) · Lebanon (2)

Largest disclosed deals

Questions

How many Algeria pharma deals has EPT tracked?
12 as of 24 Oct 2026, covering 2025–2026; 11 were announced in 2026. The most recent is Algerian laboratories → Tunisian, Mauritanian and Jordanian laboratories (Partnership / Collaboration, 24 Oct 2026).
What types of Algeria pharma deals are most common?
Technology transfer / Localization: 6 (50%); Partnership / Collaboration: 4 (33%); M&A / Acquisition: 2 (17%).
Which companies are most active in Algeria pharma deals?
Groupe Saidal (4 deals).
What is the largest disclosed Algeria pharma deal?
DKSH → NewBridge Pharmaceuticals: $390m (M&A / Acquisition, 19 Oct 2026); IMGSA → Omani Investment: $20m (Partnership / Collaboration, 3 Nov 2025). Values are as announced by the parties.

Browse deals

By region

GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)

By country

Saudi Arabia (69) · UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)

By year

2026 (193) · 2025 (27) · 2024 (6) · 2022 (3) · 2021 (2)

By therapeutic area

Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)